• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Record of Telephone Conversation, April 8, 2011 - Spherusol

Submission Type: BLA    Submission ID: 125354/0    Office: OVRR

Product:
Coccidioides immitis Spherule-Derived Skin Test Antigen
Applicant:
Allermed Laboratories, Inc.
Telecon Date/Time: 08-Apr-2011 02:30 PM        Initiated by FDA? Yes
Telephone Number: 858-292-1060
Communication Categorie(s):
1. Information Request
 
Author: JON DAUGHERTY
Telecon Summary:
Requested information on product lot(s), Clinical Study 104-1 and NDC numbers.
FDA Participants: JON DAUGHERTY, SHELDON MORRIS
Non-FDA Participants: MICHAEL DURSCHLAG
Trans-BLA Group: No
 
Related STNs: None
Related PMCs: None
Telecon Body:

We called Allermed discuss the following items. Dr. Nielsen was not available, so we spoke with Mr. Michael Durschlag.

 
Product lots(s): Mr. Durschlag said that Allermed is preparing a new lot of skin test antigen, and that the testing of the lot should be completed by the end of --(b)(4)--.

 
Clinical Study 104-1: We requested that Allermed reanalyze the data from that study without including the two subjects that reacted to the control. Mr. Durschlag will relay this request to Dr. Nielsen.

 
NDC number(s): Mr. Durschlag stated that Allermed had received advice on the procedure for requesting NDC numbers, but it found the advice to be unclear. We offered to help Allermed obtain the information in a form that will be clearer.